GlaxoSmithKline Will No Longer Pay Doctors to Shill Prescription Drugs

Shutterstock

Shutterstock

Here’s an interesting development in the medical world. Newsworks is reporting that GlaxoSmithKline, the London-based drugmaker with a huge presence in the Philadelphia region (see: the shiny new office building in the Navy Yard), will stop paying doctors to promote its drugs in a move spurred by the Affordable Care Act toward better transparency. Relatedly, GSK won’t compensate sales reps anymore, either, based on prescription sales.

Listen to this:

Mary Anne Rhyne, a GlaxoSmithKline spokeswoman, said the company headquartered in London will continue to offer educational grants to physicians, separate from its promotional efforts.


From now on, she added, it will use in-house medical personnel as education resources.

Read more over at Newsworks.

Be respectful of our online community and contribute to an engaging conversation. We reserve the right to ban impersonators and remove comments that contain personal attacks, threats, or profanity, or are flat-out offensive. By posting here, you are permitting Philadelphia magazine and Metro Corp. to edit and republish your comment in all media.